Last 971.10 INR
Change Today -15.60 / -1.58%
Volume 115.0K
HMN On Other Exchanges
Symbol
Exchange
Natl India
As of 6:05 AM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

emami ltd (HMN) Snapshot

Open
991.00
Previous Close
986.70
Day High
996.75
Day Low
953.00
52 Week High
02/13/15 - 1,046
52 Week Low
03/26/14 - 426.10
Market Cap
220.4B
Average Volume 10 Days
149.2K
EPS TTM
17.73
Shares Outstanding
227.0M
EX-Date
09/19/14
P/E TM
54.8x
Dividend
4.00
Dividend Yield
0.82%
Current Stock Chart for EMAMI LTD (HMN)

Related News

No related news articles were found.

emami ltd (HMN) Related Businessweek News

No Related Businessweek News Found

emami ltd (HMN) Details

Emami Limited manufactures and markets personal and health care products in India and internationally. It provides Himani Navratna and Navratna Extra Thanda cool oils; Boroplus advanced moisturising lotion; BoroPlus prickly heat powder; Mentho Plus Balm; Zandu Vigorex that enhances stamina and energy for a healthy and happy life; Zandu Sona Chandi Chyawanprash Plus; 7 Oils in One- damage control hair oils; Zandu Kesari Jivan; BoroPlus anti pollution daily face wash products; Zandu Balm; BoroPlus anti-septic creams; Zandu Pancharishta, an ayurvedic digestive tonic that acts on the entire digestive system, builds digestive immunity, and reduces the reoccurrence of digestive problems; Fast Relief, a pain relief ointment; Navratna Cool Talc; and Fair and Handsome, a fairness cream for men. The company was founded in 1974 and is based in Kolkata, India.

2,590 Employees
Last Reported Date: 05/5/14
Founded in 1974

emami ltd (HMN) Top Compensated Officers

Managing Director, Executive Director, Chairm...
Total Annual Compensation: 7.2M
Founder, Whole Time Director, Chairman of Fin...
Total Annual Compensation: 21.0M
Founder and Executive Chairman
Total Annual Compensation: 21.0M
Wholetime Director, Chairman of Share Transfe...
Total Annual Compensation: 5.4M
Wholetime Director, Member of Share Transfer ...
Total Annual Compensation: 5.4M
Compensation as of Fiscal Year 2014.

emami ltd (HMN) Key Developments

SBS Biotech Calls Off Talks for Kesh King Sale

Sanjeev Juneja, Promoter of SBS Biotech Limited called off the talks for sale of Kesh King, the biggest brand of SBS Biotech. Sanjeev Juneja cited valuation mismatch as the reason. Sunil Muthreja, Chief Executive Officer of SBS Biotech said that the asking price was INR 22 billion but offers received ranged between INR 17-18 billion. Deloitte India acted as advisor for SBS Biotech. Potential Buyers included Emami Limited (BSE:531162), Dabur India Ltd. (BSE:500096), Bajaj Corp Limited (BSE:533229) and Wipro Ltd. (BSE:507685) with Emami putting the highest bid.

Emami Limited Reports Unaudited Consolidated and Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Emami Limited reported unaudited consolidated and standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, on consolidated basis, net sales /income from operations was INR 6,922.6 million compared to INR 5,846.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 2,016.4 million compared to INR 1,706.3 million a year ago. Profit from ordinary activities before tax was INR 2,309.1 million against INR 1,810.7 million a year ago. Net profit was INR 1,836.9 million or INR 8.09 per basic and diluted share before and after extraordinary items compared to net profit of INR 1,506.8 million or INR 6.64 per basic and diluted share before and after extraordinary items a year ago. For the nine months, on consolidated basis, net sales /income from operations was INR 16,635.9 million compared to INR 13,750.6 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3,764.6 million compared to INR 3,056.3 million a year ago. Profit from ordinary activities before tax was INR 4,408 million against INR 3,495.4 million a year ago. Net profit was INR 3,472.6 million or INR 15.30 per basic and diluted share before and after extraordinary items compared to net profit of INR 2,913 million or INR 12.84 per basic and diluted share before and after extraordinary items a year ago. For the quarter on standalone basis, net sales /income from operations was INR 6,267.6 million compared to INR 5,500.2 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,755.4 million compared to INR 1,602.8 million a year ago. Profit from ordinary activities before tax was INR 2,094.4 million against INR 1,713.0 million a year ago. Net profit was INR 1,624.1 million or INR 7.16 per basic and diluted share before and after extraordinary items compared to net profit of INR 1,410.9 million or INR 6.22 per basic and diluted share before and after extraordinary items a year ago. For the nine months, on standalone basis, net sales /income from operations was INR 15,349.0 million compared to INR 12,949.1 million a year ago. Profit from operations before other income interest and exceptional items was INR 3,615.5 million compared to INR 2,953.4 million a year ago. Profit from ordinary activities before tax was INR 4,306.9 million against INR 3,405.5 million a year ago. Net profit was INR 3,392.9 million or INR 14.95 per basic and diluted share before and after extraordinary items compared to net profit of INR 2,830.4 million or INR 12.47 per basic and diluted share before and after extraordinary items a year ago.

Emami Limited, Q3 2015 Earnings Call, Jan 28, 2015

Emami Limited, Q3 2015 Earnings Call, Jan 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HMN:IN 971.10 INR -15.60

HMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dabur India Ltd 263.45 INR -0.90
Godrej Consumer Products Ltd 1,129 INR +2.10
Jyothy Laboratories Ltd 276.10 INR -2.15
Kose Corp ¥6,170 JPY +210.00
Marico Ltd 354.65 INR +0.15
View Industry Companies
 

Industry Analysis

HMN

Industry Average

Valuation HMN Industry Range
Price/Earnings 49.8x
Price/Sales 10.8x
Price/Book 23.1x
Price/Cash Flow 45.7x
TEV/Sales 10.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMAMI LTD, please visit www.emamiltd.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.